Nexalin Technology (NXL) EBT Margin (QoQ) (2021 - 2026)
Nexalin Technology (NXL) EBT Margin (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | Nexalin Technology | 6.98 Mn | 5.97 Mn | 8,897.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -438,705.00 |
| Mar 31, 2026 | -1.26 Mn |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | -1.03 Mn |
| Jun 30, 2025 | 260,553.00 |
| Mar 31, 2025 | 556,211.00 |
| Dec 31, 2024 | -361,208.00 |
| Sep 30, 2024 | -201,437.00 |
| Jun 30, 2024 | -345,015.00 |
| Mar 31, 2024 | 247,068.00 |
| Dec 31, 2023 | 572,530.00 |
| Sep 30, 2023 | -721,265.00 |
| Jun 30, 2023 | 13,488.00 |
| Mar 31, 2023 | -47,467.00 |
| Dec 31, 2022 | -191,865.00 |
| Sep 30, 2022 | 5,296.00 |
| Jun 30, 2022 | 1,298.00 |
| Mar 31, 2022 | 236,151.00 |
| Dec 31, 2021 | 77,329.00 |